Canopy Growth Corp (CGC) Stock Price & Analysis
Canopy Growth Corp (CGC) rose 0.00% to USD 1.02 as of June 10, 2026 at 02:21 UTC, according to Nexqual real-time market data.
CGC last closed at USD 1.02; the session ranged USD 1–1.09 on volume of 7,763,776 shares. Market capitalization is $458.06M, with a 52-week range of USD 0.84–2.38 (NMS). Source: Nexqual, June 10, 2026 at 02:21 UTC.
Key Statistics (as of June 10, 2026 at 02:21 UTC)
| Price | USD 1.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.02 |
| Open | USD 1.02 |
| Day Range | USD 1 – 1.09 |
| 52-Week Range | USD 0.84 – 2.38 |
| Volume | 7,763,776 shares |
| Market Cap | $458.06M |
| Exchange | NMS |
Technical Analysis (CGC)
Nexqual's technical model rates CGC "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 33.18 (neutral) |
| vs SMA50 | Below (USD 1.08) |
| MACD | -0.02 (negative) |
Analyst Ratings (CGC)
Wall Street analysts rate CGC "None" based on 1 analysts, with a mean price target of USD 1.76 (range USD 1.76–1.76), per Nexqual as of June 10, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 1.76 |
| High Target | USD 1.76 |
| Low Target | USD 1.76 |
| Buy / Hold / Sell | 2 / 4 / 1 |
Earnings (CGC)
| Next Earnings Date | 2026-06-15 |
|---|---|
| Revenue Estimate | $74.36M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.14 vs est -0.05 ▼ miss |
| 2025-09-30 | USD 0 vs est -0.11 ▲ beat |
| 2025-06-30 | USD -0.19 vs est -0.12 ▼ miss |
| 2025-03-31 | USD -1.32 vs est -0.21 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financials & Fundamentals (CGC)
| Total Revenue | $278.39M |
|---|---|
| Revenue Growth (YoY) | -0.30% |
| Gross Margin | +26.56% |
| Operating Margin | -17.58% |
| Profit Margin | -117.31% |
| ROE | -48.50% |
| Debt / Equity | 33.65 |
| Current Ratio | 5.34 |
| Total Cash | $371.48M |
| Total Debt | $255.12M |
| Free Cash Flow | $-25.98M |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financial Health Score (CGC)
Nexqual rates Canopy Growth Corp's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:21 UTC.
| Growth | Critical — Revenue -22% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 27%, operating -18% |
| Balance Sheet | Strong — $371M cash vs $255M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$26M, burning cash |
| Efficiency | Critical — ROE -49%, ROA -2.6% |
Ownership (CGC)
| Insider Ownership | +0.05% |
|---|---|
| Institutional Ownership | +7.72% |
| Shares Outstanding | 422.82M |
| Float | 377.58M |
| Short % of Float | +5.35% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Leadership (CGC)
Canopy Growth Corp is led by Luc Mongeau (age 57), CEO & Director, per Nexqual as of June 10, 2026 at 02:21 UTC.
| CEO & Director | Luc Mongeau (age 57) |
|---|---|
| Chief Accounting Officer & CFO | Thomas Carlton Stewart (age 43) |
| Chief Operating Officer | Michael Perron CPA, M.A. |
| Senior Vice President of Human Resources | Chrissy McHardy |
| Senior Vice President of Medical Sales | Andrew Bevan |
Major Backers & Investors (CGC)
Notable institutional backers of Canopy Growth Corp include Tidal Investments LLC, Amplify ETF Trust-Amplify Alternative Harvest ETF, Morgan Stanley, according to Nexqual as of June 10, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Tidal Investments LLC | 1.97% |
| Amplify ETF Trust-Amplify Alternative Harvest ETF | 1.97% |
| Morgan Stanley | 0.46% |
| Lazard Asset Management LLC | 0.42% |
| Jane Street Group, LLC | 0.37% |
| Goldman Sachs | 0.29% |
| Citadel | 0.26% |
| Susquehanna International Group, LLP | 0.23% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
From Canopy Growth Corp's Latest SEC 10-K Filing (filed 2025-05-30)
Key Strengths & Strategy (as disclosed to the SEC)
- Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.
- It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works.
- The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates.
- It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ACB | Aurora Cannabis Inc. | USD 3.38 | ▲ 0% |
| TLRY | Tilray Brands, Inc. | USD 5.17 | ▲ 4.66% |
| CRON | Cronos Group Inc. Common Share | USD 2.79 | ▲ 1.82% |
| CURLD | Curaleaf Holdings, Inc. | USD 10.83 | ▼ 5.91% |
| BYND | Beyond Meat, Inc. | USD 0.69 | ▼ 2.62% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:21 UTC. This page is informational and not investment advice.